title: WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study.
authors.affiliation: Frederiksborg General Hospital, Hillerød, Denmark.
authors.forename: P
authors.initials: P
authors.lastname: Bech
authors.forename: L
authors.initials: L
authors.lastname: Eplov
authors.forename: M
authors.initials: M
authors.lastname: Gastpar
authors.forename: C
authors.initials: C
authors.lastname: Gentsch
authors.forename: J
authors.initials: J
authors.lastname: Mendlewicz
authors.forename: P
authors.initials: P
authors.lastname: Plenge
authors.forename: C
authors.initials: C
authors.lastname: Rielaert
authors.forename: E T
authors.initials: ET
authors.lastname: Mellerup
mesh_terms: D001792:Blood Platelets / Q000378:metabolism*; D002352:Carrier Proteins; D003866:Depressive Disorder / Q000097:blood*; D006801:Humans; D007099:Imipramine / Q000493:pharmacokinetics*; D011869:Radioligand Assay; D011955:Receptors, Drug; D017981:Receptors, Neurotransmitter / Q000378:metabolism*
chemical_list: D002352:Carrier Proteins; D011955:Receptors, Drug; D017981:Receptors, Neurotransmitter; C027775:imipramine receptor; D007099:Imipramine